TrialSite News: Anti-Aging Distributed Drug Discovery Venture Cambrian Biopharma Announces $60m Funding & First IPO of Portfolio Company

7

 min read

11

Feb

21

Cambrian Biopharma, a new type of biotech venture raising $60 million to execute on a model known as the “Distributed Development Company” or “DisCo,” that is, a multi-asset company combining the advantages of the standard biotech firm with those of a venture capital fund and biotech incubator, to establish a platform for the development of new anti-aging therapeutics.

>